January 12, 2026 · Form 4 insider transaction
MPM BIOVENTURES 2018, L.P. bought 1,112,777 shares of AKTS at $18.00 per share, a transaction worth $20.03M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares were purchased as follows: 219,897 by BV 2018, 8,689 by BV 2018(B), 4,284 by AM BV2018, 46,574 by MPM Oncology and 833,333 by MPM Oncology Impact.; The Reporting Persons disclaim beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.; The shares are held as follows: 341,709 by MPM AM, 3,950,528 by BV 2018, 206,964 by BV 2018(B), 77,911 by AM BV2018, 847,080 by MPM Oncology and 4,835,872 by MPM Oncology Impact.